ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution

RTTNews | 708 days ago
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.

Methsuximide Capsules has been granted 180-day Competitive Generic Therapy (CGT) Exclusivity, and Alendronate Sodium Oral Solution is eligible for CGT Exclusivity upon launch.

ANI's Methsuximide Capsules are the generic version of the Reference Listed Drug (RLD) Celontin Capsules and ANI's Alendronate Sodium Oral Solution is the generic version of the RLD Fosamax Oral Solution.

The current annual U.S. market for Methsuximide Capsules and Alendronate Sodium Oral Solution is approximately $6.3 million, according to IQVIA, a leading healthcare data and analytics provider.

read more
CAC 40 Down Marginally

CAC 40 Down Marginally

The French stock market is down marginally on Tuesday as investors, amid lingering concerns over U.S. Government's trade policy and rising tensions between the U.S. and China, largely remain cautious while awaiting some crucial economic data and earnings updates this week.
RTTNews | 16 minutes ago
DAX Recovers After Early Setback, Down Marginally In Cautious Trade

DAX Recovers After Early Setback, Down Marginally In Cautious Trade

German stocks are down in negative territory on Tuesday, with investors, back to trading after a long Easter break, making cautious moves amid lingering concerns about trade tensions due to the U.S. government's trade policy. The standoff between the U.S. President and the Federal Reserve Chair also appears to be weighing on investor sentiment.
RTTNews | 52 minutes ago
Walgreens To Pay Up To $350 Mln For Opioid Settlement

Walgreens To Pay Up To $350 Mln For Opioid Settlement

Walgreens Boots Alliance and its units have agreed to pay up to $350 million as it settles with the Justice Department and other federal agencies the allegations of illegally filling unlawful opioid prescriptions and submitting false claims to the Federal Government.
RTTNews | 2h 11min ago